🇺🇸 FDA
Patent

US 7531500

Preventing airway mucus production by administration of EGF-R antagonists

granted A61KA61K2039/505A61K31/00

Quick answer

US patent 7531500 (Preventing airway mucus production by administration of EGF-R antagonists) held by The Regents of the University of California expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K31/00, A61K38/177, A61K38/446